PTX3 and hepatocellular carcinoma: In patients under antiviral treatment, PTX3 levels had an AUC (95%CI) of 0.923 (0.865–0.982), sensitivity of 80%, and specificity of 89.47% for HCC in chronic HBV infection without HCC.